Biogen Inc
NASDAQ: BIIB
$146.23
+$1.82 (+1.3%)
Closing Price on January 30, 2025
BIIB Articles
Jon OggInvestors and traders alike are looking for ideas and recommendations now that the government shutdown is here and with a debt ceiling debate ahead. Each morning 24/7 Wall St. reviews dozens...
Published:
Investors and traders are worried about an end to quantitative easing, yet stocks are rallying hard on fundamentals. This puts these same investors in a spot where they have to wonder which stocks to...
Published:
Last Updated:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Monday, July 1, 2013. They include Apple, BlackBerry, 3M and Best Buy.
Published:
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise, is the difference...
Published:
June 28, 2013: U.S. equity markets opened lower this morning after a few days of stronger openings, mainly because investors were waiting for some economic data. They didn’t have to wait long as...
Published:
Last Updated:
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems like an...
Published:
Last Updated:
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, June 12, 2013. They include Biogen Idec, Dean Foods, Kinross Gold and Wells Fargo.
Published:
Last Updated:
ThinkstockOnce again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last...
Published:
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28%...
Published:
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
Published:
Last Updated:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
Jon OggInvestors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. They often do not get to see when analyst downgrade stocks to sell or to avoid. We review many...
Published:
Last Updated:
The end of March brought on the last trading of the quarter, with the S&P Index hitting new all-time closing highs in what felt like a very choppy couple of weeks. While we still have not raised...
Published:
Last Updated:
U.S. equity markets opened slightly higher this morning even following a larger than expected rise in new claims for jobless benefits in the U.S. The final revision to fourth quarter 2012 GDP...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.